Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BBS1 |
| Upstream (Parents) |
|---|
| (<<) ATN1 → BBS1 |
| (<<) HSPA14 → BBS1 |
| (<<) MAP3K11 → BBS1 |
| (<<) PLD2 → BBS1 |
| (<<) PNO1 → BBS1 |
| (<<) TNF → BBS1 |
| (<<) TYK2 → BBS1 |
| Downstream (Children) |
|---|
| BBS1 → ADCY6 (>>) |
| BBS1 → BAD (>>) |
| BBS1 → CALML5 (>>) |
| BBS1 → CRCT1 (>>) |
| BBS1 → DEAF1 (>>) |
| BBS1 → DNAJA1 (>>) |
| BBS1 → DVL1 (>>) |
| BBS1 → GNB1 (>>) |
| BBS1 → ICAM2 (>>) |
| BBS1 → MCL1 (>>) |
| BBS1 → MYL5 (>>) |
| BBS1 → NEUROG1 (>>) |
| BBS1 → PRKACB (>>) |
| BBS1 → PTPN11 (>>) |
| BBS1 → RTN3 (>>) |
| BBS1 → SALL2 (>>) |
| BBS1 → SOS1 (>>) |
| BBS1 → VEGFB (>>) |
